How much is Siponimod reimbursed by medical insurance?

Siponimod (Siponimod) is a drug used to treat multiple sclerosis (Multiple Sclerosis, referred to as MS). Multiple sclerosis is an autoimmune disease that affects the central nervous system (including the brain and spinal cord), causing the immune system to attack the protective myelin sheath of nerve fibers, thereby interfering with nerve signal transmission and causing a series of neurological problems.

Siponimod has been launched in China and has been included in medical insurance. Patients can purchase it domestically. For specific prices and reimbursement status please consult the local hospital pharmacy. For overseas prices, please consult Yaode’s medical consultant.

Siponimod belongs to a class of drugs called antagonistS1Preceptor modulators. S1PThe receptor is a molecule that affects the movement and distribution of immune system cells. By modulating the S1P receptor, siponimod helps reduce certain activities in the immune system, thereby reducing immune system attacks on the central nervous system, reducing symptoms of multiple sclerosis and slowing the progression of the disease.

The use of siponimod usually requires a doctor's prescription and needs to be used under clinical supervision because it may cause some side effects and safety risks. This drug can help reduce relapses of multiple sclerosis and improve patients' quality of life.

Please note that drug information may change over time, so when using or getting the latest information about siponimod, consult your professional health care provider or refer to the latest medical literature and drug package inserts.